262 related articles for article (PubMed ID: 18312772)
1. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
Lee TM; Lin MS; Chang NC
Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
[TBL] [Abstract][Full Text] [Related]
2. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Lee TM; Chen CC; Shen HN; Chang NC
Clin Sci (Lond); 2009 Mar; 116(6):497-505. PubMed ID: 18831711
[TBL] [Abstract][Full Text] [Related]
3. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design.
Albert MA; Staggers J; Chew P; Ridker PM;
Am Heart J; 2001 Jun; 141(6):893-8. PubMed ID: 11376301
[TBL] [Abstract][Full Text] [Related]
4. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
5. Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol.
van der Harst P; Asselbergs FW; Hillege HL; Bakker SJ; Voors AA; van Veldhuisen DJ; van Gilst WH;
Am J Cardiol; 2007 Nov; 100(10):1548-51. PubMed ID: 17996517
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
7. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
[TBL] [Abstract][Full Text] [Related]
8. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.
Hernandez TL; Capell WH; Wolfe P; Gerard LA; Eckel RH
Am J Cardiol; 2006 Dec; 98(12):1656-9. PubMed ID: 17145229
[TBL] [Abstract][Full Text] [Related]
9. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
Corte TJ; Wort SJ
Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
[TBL] [Abstract][Full Text] [Related]
11. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
[TBL] [Abstract][Full Text] [Related]
12. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
13. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
14. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
15. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease.
Broekhuizen R; Wouters EF; Creutzberg EC; Weling-Scheepers CA; Schols AM
Thorax; 2005 May; 60(5):376-82. PubMed ID: 15860712
[TBL] [Abstract][Full Text] [Related]
16. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the early administration of pravastatin on C-reactive protein and interleukin-6 levels in the acute phase of myocardial infarction with ST segment elevation].
Gonzálvez M; Ruiz Ros JA; Pérez-Paredes M; Lozano ML; Giménez DM; Martínez-Corbalán F; Carnero A; Cubero T; Gómez AE; Vicente V
Rev Esp Cardiol; 2004 Oct; 57(10):916-23. PubMed ID: 15469788
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
[TBL] [Abstract][Full Text] [Related]
19. Effect of pravastatin on markers of endothelial activation in dialysis patients.
Jeffs LS; Skilton F; Nitschke J; Bannister KM; Faull RJ
Nephrology (Carlton); 2007 Jun; 12(3):234-8. PubMed ID: 17498117
[TBL] [Abstract][Full Text] [Related]
20. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
